You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 19 Dec 2025
Cancer Type:
Gastrointestinal, 
Colorectal
Intent: Palliative
Other Info:
Previously treated patients
Revision Summary:
Regimen Monograph: Formatting change
Updated
Dec 2025
Regimen
Published Date: 19 Dec 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Adverse Effects section

Updated
Dec 2025
Drug

Published Date: 18 Dec 2025

Revision Summary:
Drug Monograph: New drug monograph
Patient Info Sheet EN: New patient medication information sheet
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Updated
Dec 2025
Drug

Published Date: 18 Dec 2025

Revision Summary:
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Updated
Dec 2025
Drug

Published Date: 18 Dec 2025

Revision Summary:
Patient Info Sheet EN: Updated "Will this treatment interact with other medications or natural health products?" section
Patient Info Sheet FR: Updated/revised patient information sheet (Fiche d'information mise à jour/revisée)
Updated
Dec 2025
Drug

Published Date: 17 Dec 2025

Revision Summary:
Patient Info Sheet EN: Updated "Do not do this while on treatment" section
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Updated
Dec 2025
Drug

Published Date: 17 Dec 2025

Revision Summary:
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Updated
Dec 2025
Drug

Published Date: 16 Dec 2025

Revision Summary:
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Updated
Dec 2025
Regimen
Published Date: 12 Dec 2025
Cancer Type:
Hematologic, 
Lymphoma - Hodgkin
Intent: Curative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, Drug Regimen and Cycle Frequency sections

Updated
Dec 2025
Drug

Published Date: 12 Dec 2025

Revision Summary:


Drug Monograph: Updated Supplementary Public Funding section

Updated
Dec 2025
Regimen
Published Date: 11 Dec 2025
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Supplementary Public Funding section (everolimus ODB general benefit)

Updated
Dec 2025
Regimen
Published Date: 11 Dec 2025
Cancer Type:
Lung, 
Neuroendocrine (Lung)
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Supplementary Public Funding section (ODB general benefit)

Updated
Dec 2025

Pages